In sum, our results suggest that a reduced expression of LGALS3BP is one of the factor responsible of the malignant progression of CRC and implicates poor prognosis This notion could represent a potential strategy for prevention or treatment of CRC growth and progression. Here, LGALS3BP is linked to colorectal carcinoma.